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The leptin receptor mutation of the obese Zucker rat causes sciatic nerve
demyelination with a centripetal pattern defect
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ABSTRACT
Young male Zucker rats with a leptin receptor mutation are obese, have a non-insulin-dependent
diabetes mellitus (NIDDM), and other endocrinopathies. Tibial branches of the sciatic nerve reveal a
progressive demyelination that progresses out of the Schwann cells (SCs) where electron-contrast
deposits are accumulated while the minor lines or intermembranous SC contacts display exaggerated
spacings. Cajal bands contain diversely contrasted vesicles adjacent to the abaxonal myelin layer with
blemishes; they appear dispatched centripetally out ofmany narrow electron densities, regularly spaced
around the myelin annulus. These anomalies widen and yield into sectors across the stacked myelin
layers. Throughout the worse degradations, the adaxonal membrane remains along the axonal neuro-
plasm. This peripheral neuropathy with irresponsive leptin cannot modulate hypothalamic-pituitary-
adrenal axis and SC neurosteroids, thus exacerbates NIDDM condition. Additionally, the ultrastructure of
the progressive myelin alterations may have unraveled a peculiar, centripetal mode of trafficking
maintenance of the peripheral nervous system myelin, while some adhesive glycoproteins remain
between myelin layers, somewhat hindering the axon mutilation.
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Introduction
In basic neuropathology texts, demyelination could
be acute or chronic. However, the etiology of the
degenerative process related to the nourishing layer
of nerve fiber’s myelin, either involving the central or
the peripheral nervous system (PNS), is complex and
still poorly understood. 1–6 In dealing with periph-
eral neuropathies, textbooks bring the topic along
with neuromuscular anomalies. 7 The defects are
classified either as (a) axonal neuropathies in which
insults of the axons often consist in degeneration
occurring distally and secondarily to damage the
myelin or (b) as demyelinating neuropathies char-
acterized by Schwann cell (SC) changes wherein
myelin would display abnormal conduction veloci-
ties. This latter type of neural defect is apparently
short-sized and can appear randomly to reduce the
internode myelin sheaths while maintaining the
axonal content. There, changes occurring in the
PNS endoneurium have been seldom investigated.
8–10 Recent advances about cooperativity between SC
basal lamina components and axon have revealed
paracrine and juxtacrine interactions with at least
one of the neuregulins. 11,12
This report encompasses the fine structure of scia-
tic nerve demyelination injuries in the young male
Zucker rats. A preliminary study of this topic 13
followed investigations that have dealt with other
endocrinopathies, such as thyroid gland dysfunctions
(hypothyroidism 14–27 and hypercalcemia 14–16),
motricity 27 along with a non-insulin-dependent dia-
betes mellitus (NIDDM) or diabetes type 2 14–17 In
this rat strain, these defects have been linked to a
leptin receptor mutation 28–36, comforted by pancrea-
tic changes. 37–39 Additionally, this leptin receptor
defect provokes other hypothalamo-pituitary axis
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failures. 40–42 Because PNS demyelination defects are
often viewed by light microscopy (LM) and not well
illustrated with fine structure, we have aimed to docu-
ment further ultrastructural information on diabetes-
related neuropathy.
Interestingly, the Zucker obese rats bore myelin
anomalies resembling the ones found in toxicant-
induced diabetes in animals 43–52 and probably also
those – not studied by fine structure – found in
unusual human cases of diabetes where leptin recep-
tor was similarly incompetent. 53–69 Therefore, the
discussion of our demyelination data includes dia-
betes type 2 considerations along with leptin-linked
endocrine interactions.
Our micrographic illustrations have been
arranged in a progressive peripheral nerve defects
sequence that could supplement those found in
human diabetes biopsies or those of testing animal
for diabetes and treatments. Additionally, both a
preliminary report presented in Lisbon meeting 70
and the analysis of the myelin defects collected
could have unveiled another possible molecular
dynamic mechanism, dealing with the mainte-
nance of the PNS myelin membranes and compo-
nents that could involve a centripetal diffusion out
of either the SCs, marked by an excessive content
in electron-contrasted species.
Materials and methods
The Institutional Animal Care and Use Committee of
the Northeastern Ohio Universities College of
Medicine (now named ‘Northeast Ohio University’),
Rootstown, Ohio, USA have approved the procedures
of animal care, anesthesia, euthanasia, and tissue’s
collection of this study and concomitant ones. 40,41
Terminology: Lean Zucker rats have a possible
genotype of the dominant trait Fa homozygous (Fa/
Fa) or heterozygous (Fa/fa), hence called Fa/?, where
the interrogation mark indicates whether fa or Fa
trait is associated with another fa trait (weight) with-
out being unable to verify the corresponding leptin
receptor genotype. 12–18 Phenotypically, the obese
Zucker rats possesses both recessive traits (fa/fa)
and consistently showed significant overweight at
matching age.
Five young obese male Zucker rats (fa/fa; 3 month
of age, 398 ± 21.2 g) and five lean littermates (Fa/?)
(201 ± 13.5 g) obtained out of a colony originally
purchased from Charles River Laboratories (Raleigh,
NC) and derived from an original stock 10–13 were
housed individually and maintained on a 12 h-light/
12 h-dark cycle (light from 06.00 to 18.00 h). Rats fed
rodent chow (Purina, St Louis, MO) and water ad
libitum. Anesthetized with ether 71 rats were perfused
with warm saline (38°C) through aorta for 5min; then
saline was then replaced by an ad hoc fixative to allow
other studies. The fixative was a mixture of 3% glutar-
aldehyde–paraformaldehyde (1:1) buffered by phos-
phate buffer (pH 7.3–7.4) 72 for 30 min in cold
temperature because tissues were primarily used for
immunohistochemistry investigations and one not
necessarily ultrastructure. Excision of sciatic nerve
branches, other organs, and tissues occurred after
brain removal was performed by others 40,41 as
exploratory investigations with the aim of potential
other studies on these rodents. At the time, no quan-
titation was planned or performed.
Out of all the lean (Fa/?) and obese (fa/fa)
perfused rat carcasses, several (5–12 mm) seg-
ments excised from the sciatic tibial nerve
branches were not blind-collected; they were
fixed another hour in the same fixative 72, washed
in cacodylate buffer for 30 min (0.1M Na cacody-
late buffer, pH 7.35 and sucrose) and post-fixed
2 h by 2% OsO4 aqueous solution. Samples were
dehydrated, cleared and processed in PolyBed
epoxy resin (Polysciences, Warrington, PA). One-
micrometer thick sections stained with toluidine
blue were examined in an Olympus BX51 photo-
microscope (Olympus America, Melville, NY).
Selected areas of LM were ultrathin sectioned,
collected on 50- and 75-mesh hexagonal copper
grids (SPI, West Chester, PA), stained in uranyl
acetate and lead citrate before they were examined
in a Zeiss EM-10 transmission electron micro-
scope (TEM; Carl Zeiss, Thornwood, NY).
Results
Light microscopy
Comparisons between the 1-µm thick sections of
lean (Figure 1(a,b)) and obese (Figures 4(b) and
5(a,b)) rat sciatic tibial nerve specimens reveal
that, in both lean and obese nerves, the popula-
tion of large and small myelinated and unmye-
linated fibers can be viewed in all the samples of
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nerve branches, including a few single intramus-
cular ones. However, LM aspects poorly resolve
differences at the highest magnifications or by
enlarging the micrographs through computeri-
zed captures. The oblique to longitudinal sec-
tions of the fa/fa sciatic nerve branches and
intramuscular fiber profiles, stained with tolui-
dine blue, displays a myelin layer with peculiar
whorls or sieve-like aspects. Additionally, in the
obese rat nerves, swollen axons and a less dense
internode myelin staining can be found com-
pared with the lean ones. It is only by
Figure 1. (a–c) Lean Fa/? Zucker rat sciatic nerve. One-micrometer thick sections of tibial branches of the sciatic with its epineurium
(a,c). Toluidine blue stain. (a): Example of a large branch with tight fascicles contained in the perineurial sheath and two adjacent
small branches. The central region contains an obvious vasa nervorum. In (c): A small intramuscular nerve subdivision. Scale in (a)
and (b) is 10 µm. (b): TEM pane mounted out of nine micrographs of a further intramuscular branch of (c) demonstrating two small
fascicles of five fibers each, surrounded by the epi- and perineurial fibers and an endoneurial loose connective tissue where nerve
fibers show their densely contrasted myelin; the most folded ones likely denote their near- or paranodal region. Scale is 5 µm.
Figure 2. (a–b) Lean Fa/? Zucker rat. TEM of cross-sections of isolated intramuscular nerve fibers both surrounded by their
endoneurial connective fibers (e). The small part of Schwann cell viewed in intermodal cross-section is the Cajal band, its intranodal
myelin and narrow cytoplasm, surrounded by its basal lamina Scale is 1 µm.
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ultrastructure examination that differences
between lean or Fa/? nerves can be verified
(Figures 1(c), 2(a,b), and 3(a,b)), such as the
fine and vacuole-like blemishes revealed along
the myelin of the nerve fibers of obese fa/fa
nerves (Figures 4(a) and 5(a)–16).
Figure 3. (a–b) Lean Fa/? Zucker rat. Both TEM views of an internodal segment of myelin from either Figure 1(c) or 2(a or b) showing
its typical basal lamina and the characteristic layering of myelin insulation with 12.5 nm periodicity of the major dense lines spaced
by a middle 6.0–6.3 nm minor dense line or intraperiod, corresponding to the external leaflets of the Schwann cell neurilemma. A
vasa nervorum endothelium, rich in endo-exocytotic vesicles and its basal lamina is also shown in (a) where the axoplasm contains
its neurofibrils and a few neuroreticulum saccules adjacent to adaxonal membrane. (b) is (a) magnified. Scale in (a) is 500 nm and in
(b) 12.5 nm is the major dense line periodicity.
Figure 4. (a–b) Obese Zucker rat. (a): LM view of 1 µm-thick cross of a sciatic tibial nerve branch. Toluidine blue stain. Scale is 10 µm.
(b): TEM micrograph montage reconstituting a view of (a) section. This pane depicts diverse myelinated fiber damages, in oblique
and cross-sections. Some of them were enlarged to further illustrate this study. Note the myelinated and a few Remak nerve fibers
accompanied by a loose endoneurial and perineurial supportive tissue. Scale is 1 µm.
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Transmission electron microscopy
TEM observations further confirm that no altera-
tions affect the lean rat nerves (Figures 1(c), 2(a,b),
and 3(a,b)), while all the obese rat myelinated
nerve samples display some demyelinating
damages and worse are found to be proportional
Figure 5. (a–c) (a–b) One-micrometer thick longitudinal to oblique section of a sciatic tibial nerve branch of an obese Zucker rat.
Toluidine blue stain. Scales are 10 µm. (a): Example of field of view that shows how difficult is LM resolution to verify whether
alterations have occurred but the tiny, poorly stained bulges (*) while nerve fibers’ internodes appear swollen. (b): Tangential views
of most myelinated fibers of a fascicle denote changes in myelin with spaced vacuolizations of the insulating myelin that can appear
as dark Swiss cheese (upper area). In both (a) and (b) Schmidt-Lantermann areas can be noticed as if oblique gashes in the myelin
(both left middle areas). (c): TEM detail of an oblique to longitudinal aspect of one nerve fiber of (b) that resolves the spaced
vacuoles and the bulging segments in the myelin to be sectors of focal, demyelination. An endoneurial fibrocyte is adjacent to this
nerve fiber section and demonstrates multiple contrasted deposits. Scales equal 10 µm in (a) and (b), in (c) is 1 µm.
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to their diameter size (Figures 4(b) and 5(b)–16).
In the following paragraphs, descriptions of nerve
fiber injuries of the obese rat nerves are organized
to depict the progression of the damages, from the
smallest to the worst, comforting the neuropathic
changes associated with the NIDDM-associated
leptin receptor defect of this rat strain.
Lean (Fa/?) Zucker rat sciatic nerves
Myelinated fibers. In these fibers, the neurolem-
nocyte or SC cytoplasm of some small or large
nerve fibers reveals typical indent of the perikaryal
areas (not shown here); it contains typical cell
organelles. The SC nucleus, with its perikaryon,
is in the median internode regions of each periph-
eral nerve fiber, thus the internodal cytoplasm is
most often viewed as a narrow band with the
random TEM sections, named Cajal band. This
‘band’ of the SC contains the abaxonal region
with its outermost myelin layer and sheaths
where, by place, outer mesaxons can be viewed
(Figures 1(c) and 2(a,b)). The axoplasms show
mitochondria, neurotubules, neurofibrils, and a
few adaxonal neuroreticulum cisternae. In the rat
tibial branches, most nerve fibers are typically
myelinated and organized by SCs in concentric
tight layers of neurilemma forming an electron
dense Fermat-like spire enclosing the neurites,
whether found in cross or oblique, or low-magni-
fication sections (Figure 3(a)).
Viewed at a higher resolution, the myelin dis-
plays the internodal myelin tightly organized,
with its regularly distanced membranous archi-
tecture and adhesive contacts. There, the typical
major dense lines are viewed as highly con-
trasted thick ‘lines’ which are observed ranging
between 12.5 and 15.5 nm distance periodicity.
There, the thinned SC cytoplasm is spaced by
weakly contrasted intraperiod lines (or minor
lines) that appear with poor contrast, containing
Figure 6. (a–d) TEM of obese rat sciatic nerve. In (a–c): Semi-serial TEM views of perikaryal SC (or parts of Cajal bands containing a
mitochondrium, smooth and rough endoplasmic reticulum, polyribosomes and a lipid deposit (dense arrow)) enlarged in insert near
(b) showing that no membrane lines the lipid-like inclusion, i.e. not a ‘vesicle’. (b): similar area of Cajal band; TEM view as in (a)
showing the same lipid deposit. (c): Cajal band perikaryal area of an obese nerve fiber showing a mesaxon area. Long mitochondria
cut (m) are shown adjacent to electron dense vesicles or deposits adjacent to a Golgi cistern containing a fibrillar striated content
(prepro-collagen?). (d): Small nerve fiber with its SC nucleus and perikaryon with a disorganized mesaxon complex. The curved
arrows mark defects in the mesaxon, abaxonal myelin, leaving intact the adaxonal membrane. Scales in (a–d) are all equal to 1 µm.
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the adjacent contacting membranes of one inter-
nodal wrapping SC. The periodical distance
between major lines can reach between 20 and
300 nm in width, the widest often located at the
level of Schmidt–Lantermann (S-L) and the
nodal zones (Figure 3(b)). In cross-section,
each entire myelin insulating profile shapes like
an annulus, somewhat circular but folded up
near and at the Ranvier’s nodes. The adjacent
to axolemmal with its adaxonal SC cytoplasm, or
so-called Mauthner’s layer, is quasi inexistent
due to the compaction of myelin.
Unmyelinated nerve fibers. A few unmyelinated
(Remak-like) fibers can be found among the endo-
neurial stroma adjacent to the myelinated ones but
are not illustrated in Figure 1, especially when one
has enlarged the small intramuscular sciatic nerve
branches.
The supportive stroma including endoneurium.
This stroma, associated with the basal laminae
produced by the SCs, surrounds every fiber
whether myelinated or unmyelinated. The endo-
neurium reveals its loose endoneurium containing
Figure 7. (a–d) TEM of sciatic nerve fibers of obese Zucker rat with initial myelin damages. (a): Twin dense arrows respectively mark
the first and second intraperiod lines spaced with electron dense eposits adjacent to the Cajal band; small arrows and bl: indicate the
basal laminae of adjacent nerve fibers. (b): Electron dense deposit enlarges and widen along 9–10th intraperiod line level. (c):
Example of small abaxonal cisterns in Cajal band along the outermost myelin sheath. These damages continue as cone-like profiles
to reach the adaxonal membrane as discrete to wide intermembranous spaces. (d): example of internodal cross-section with narrow
Cajal band where discrete myelin blemishes initiate and a deformed adaxonal membrane, as shown on adjacent fibers. All the scales
are equal to 1 µm.
ULTRASTRUCTURAL PATHOLOGY 383
scattered fibroblasts, dispersed bundles of collagen
fibers, in the interstitial, extracellular matrix loose
connective tissue, and few small blood vessels
(Figure 1(a)). The perineurium is constituted by
adjacent fibrocyte-like cells providing nerve
fascicle or even single-nerve fiber external support,
as epineurium subdivisions branch and resolve
into perimysium. This one is a thin fibroblastic
sheath, creating a surrounding channel around
each nerve fiber, as endoneurium with the
Figure 8. Enlarged sector of a fa/fa sciatic nerve fiber showing the Cajal band contains either marbled (arrow) or emptied-like
vacuoles facing the abaxonal membrane (arrow) seemingly in contact with the abaxonal myelin, displaying ovoid-shaped alterations
rupturing locally the periodicity of the packed myelin annulus. Note along its perimeter and through that annulus the aligned dense
component that contrasts as electron dense striped lines into the initial myelin layers that reach deep in it. The basal lamina
surrounds the entire SC with its noted extracellular matrix. Scale equals 500 nm.
Figure 9. TEM of obese Zucker rat. A narrow sector of a sciatic nerve with at high magnification showing intraperiod lines or spaces
containing densely contrasted elongated hyphen-like buttons in the mid-regions, corresponding to adhesive ‘rivets’ that holds
myelin major lines or attachments between the fissuration damages. Scale is 15 nm between two major dense lines.
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intercellular basement membrane-like and the
basal lamina of the SCs (Figures 1(a–c) and 2(a,
b)).
Obese rat (fa/fa) sciatic nerves
Myelinated fibers. Low magnification demonstrates
that all the samples from obese nerves have damaged
nerve fibers shown with LM in a small branch of the
sciatic nerve (Figures 4(a,b) and 5(a,b)). Among the
smallest fibers alterations, some nerve fibers display
defective myelin tight organization in the outer
mesaxon of the SC cytoplasm where altered wrapping
membrane can be seen while the axoplasm content
seems untouched (Figures 4(b) and 5(c)–13). Further
away from the perikaryon, internodal SC zones show
other disruptions or anomalies in the outer and inner
mesaxons with adjacent debris to the tight myelin
(Figure 15) even though SCs appear to reveal typical
nucleus with perikaryal organelles, clusters of dilated
cisterns of rough and smooth endoplasmic reticulum,
Golgi parts, intermingling polysomes, and mitochon-
dria are recognized (Figure 6(c,d)). In Figure 6(c), an
example of a lucky field of view displays an elongated
deposit droplet (no limiting membrane) seemingly or
faintly striated but of unclear nature can accompany
other few endoplasmic cisterns where sometimes a
fibril of collagen precursor (pro-collagen?) is viewed;
one could interpret it to be later secreted as part of the
basal lamina (Figure 6(d)). At all stages of damage, the
nerve fibers show inner mesaxon changes or anoma-
lies in alignment as well as for the adaxonal lining. The
neuroplasm reveals swelling of the neuroreticulum
but no apparent fibrillar or microtubular changes
(Figures 4(b) and 9–13). Near one Golgi cistern,
Figure 10. (a–d): TEM views of obese Zucker rat sciatic nerve fibers cross (a, b, and d) and oblique (c) internode sections
demonstrating the spaced vacuolated defects revealed across the width of the myelin annulus sheaths displaying a sort of conical
shape, narrow in abaxonal side and enlarged in the adaxonal region. The interval spaces can branch into smaller defects. Either
damages favor bulges of the adaxonal membrane and can reveal an axonal content vacuolated. In (d), Cajal band shows several
vacuoles as noted in Figure 8. Scales are 1 µm.
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adjacent electron dense vesicles (lysosomes?) are
noticed (Figure 6(d)). The basal lamina always tightly
surrounds all SCs and does not appear with any dis-
continuities in all TEMviews throughout the nerve. In
the endoneurium, collagen eventually shows errati-
cally organized fibers and bundles (Figure 4(b)).
Initial damages. At first, thought to be artifacts,
minute myelin changes appear as if narrow broad-
enings of a few abaxonal and outermost major
dense lines with exaggerate electron dense content
or deposits; these appear made of fine granular-
like aspect caused by tissue processing, revealing
their anionic content (Figure 7(a–c)). Noticed in
the first and second major abaxonal lines, these
peculiar deposits appear to also widen the cyto-
plasmic compartment of the SCs and the inter-
membranous spaces separating the intraperiod or
minor dense lines, i.e. extracellular faces of adher-
ing SC’s membranes. The defects correspond with
a disjointing of adhering membranes of the
internodal myelin. Similar SC deposits are noticed
at the mid-level of the myelin (Figure 7(b)) made
of unwrapping adjacent myelin sheaths, then
enlarged slits rip them apart in an apparent cen-
tripetal way. Initiated in the Cajal band nurturing
the myelin, the membrane defects appear as tiny
teared sectors that ‘diffuse’ by accretion into each
innermost adjacent layer of myelin minor lines.
There, membrane separation expansions broaden
and disorganize the tight concentric myelin layer-
ing by accumulated contrasted (and, maybe,
poorly contrasted) materials between adjacent,
intervening cytoplasmic tongues thus create rifts
within the myelin annuli. Overall damages create
injuries in the shape of conical pockets pointing
outwardly. Therefore, the morphology of the
damages reinforces the idea of a centripetal pro-
gression toward the adaxonal membrane, ending
brutally as a wide elongated slit at this membrane
or, earlier, within the myelin sheaths. These altera-
tions then appear to branch as sectors with inward
Figure 11. TEM of adjacent obese Zucker rat sciatic nerve fibers with internodal, variable size, enlarged demyelinating sectors and their
narrow Cajal bands with pale vacuoles. Defects appear initiated at the abaxonal Cajal band myelin layer with regularly spaced narrow,
electron contrasted ‘sinks’ enlarged toward the adaxonal layer with obvious onion-like rifts. A curved arrowmarks altered adaxonal myelin
to be compared with the adjacent fiber where the onion-shape blemish bulges into the axonal space. Scale equals 1 µm.
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progress, thus widen the defect zones, as noted
according to the randomness of the examined
nerve fibers sections (Figures 5(c), 7(c,d), 8, and
9–11).
Demyelination progress. The myelin degradations
appear to be the worst at the level of the largest
diameter fibers. Again, the defects begin in the narrow
regions of the Cajal bands. There, oblong vesicles,
ranging from 60 to 150 nm in diameter, with marbled
content or similar sized vacuoles can be viewed adja-
cent to or in contact with the outermost sheath of the
abaxonal myelin. Interestingly, most vesicles face the
sites where the initial series of myelin blemishes or
sector fissures occur (Figures 8, 9, 10(a–d), and 12(a–
f)). Other views of the fissures can also resolve into
Figure 12. (a–f): TEM aspects of obese Zucker rat sciatic nerve obtained out of thick ultrathin (>500 nm). (a–d): Near entire cross-
sections show damages of myelin to appear as ‘bubbles’ across several layers of myelin sheaths with higher resolution in (b), (d), (e),
and (f). Fusing with each other, myelin degrades throughout with stacked faults or crevices, rupturing sectors with cracks out of
internal pockets or wide gashes, leaving intact the adaxonal membrane and the content of the axoplasm. Debris includes waxy,
electron dense deposits in the large spaces. Small fatty-like vacuoles in the Cajal bands can be seen in (b)–(f) (arrows). All scales are
equal to 1 µm.
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further emptied spaces separating myelin layers’ pile-
ups. At first, the aligned defect distribution reminds of
widenings of the radial lines in central nervous system
(CNS) as they are regularly spaced along the myelin
annulus profiles (Figures 5(c) and 9–12(b)). These
accumulated, piled-up mutilations are sometimes
aligned in the oblique and near longitudinal sections
suggestive of sorts of intraperiod damages propagated
along the outermost layer of the myelin in a periodic
fashion of growing faults toward the adaxonal mem-
brane. The degradation pockets appear as sieve-like
with LM (Figure 5(b)) and confirmed with TEM
(Figure 11(a–f)). They create inner curved bulges in
transverse sections, also with onion-like aspect limited
by the inner adaxonal membrane, initially viewed as
minor bulges (Figures 5(c), 7(d), 8, 10(a–d), 11, and 13
Figure 13. (a–e): Obese Zucker rat sciatic nerve fibers with aspects of demyelination found as circumferential fissuring of the
internodal and paranodal zones as thick onion peeled. Complex whorls with waxy debris are noted in the spaces formed. (a–c):
Almost complete splits with adaxonal membrane partly detached from the damaged myelin (curved arrow in (b)). (d–e): complete
splits of myelin annulus form quasi two encircling rings out of the intact, single myelin annuli built as spiral (i.e. suggested in (c)).
Scales are all equal to 1 µm.
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Figure 14. (a–c): Pane with paranodal (a–b) to nodal (c) cross-sections of sciatic nerve fibers of an obese Zucker rat with the worse
demyelination. (a): Cracks of the myelin annulus with diverse debris and shredded axonal content. (b): Peculiar aspect of paranodal
zone with myelin layers retaining points of adhesion (torn in small linkers) creating a peculiar labyrinthine pattern caused by the
processing and infoldings of the myelin. (c): Folded node of Ranvier’s region in cross-section with highly contrasted myelin layers
with loosen circumferential fissures making the appearance of onion-like aspect and showing a detached adaxonal membrane. In all
views, the chaffed SC basal lamina and the axoplasm is reduced into a minute central target-like zone. Scales are 1 µm.
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(b)). The partial or quasi-complete alteredmyelin now
encompasses dissecting damages through expanded
fissures into vacuolated spaces that progress as seg-
ments with intervening exaggerated spaces along the
circumference of themyelin annulus sections (Figures
4(b) and 13(a–e)). Finally, more fused or coalescent
fissures peel off layers of still adherent sheaths of the
insulating inner layer (Figures 13(a–e) and 14(a–c)).
Figure 15. Near nodal region of an obese Zucker fa/fa rat sciatic nerve fiber. This typical folded region of a myelinated fiber
demonstrates apparent myelin adhesion defects not so different that typical node fine structure but appear as large, loosened, open
onion-like sectors along with interstices of obliquely-cut tight myelin appears packed, as electron dense stripes. The axoplasm
content is vacuolated and the myelin depicts a large star-shaped overall aspect due to partial unwrapping of the myelin layers near
the Ranvier node. Scale is 1 µm.
Figure 16. Schematic representation of adipose tissue’s leptin influences with feedbacks on CNS, PNS, and endocrines.
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Either erratic or wavy layers reveal the sector’s rough
devastation that eventually completely dissects the
myelin, hacking the entire myelin annulus (Figure 14
(c)). The gashes perforate or ruin the entire myelin
layer (Figure 14(a–c)).
Altogether, these defects do not usually include
the adaxonal membrane (Figures 5(c), 10(d), 11,
and 12(a–f)). These micrographs with important
tearing of the myelin show inward vacuole-like
spaces lined by the adaxonal membrane, leaving
separated the intact neuroplasm and the axonal
content. These myelin tearings feature all sorts of
membranous debris, including some waxy, elec-
tron dense remnants (Figures 4(b), 11, 12(a–f),
13(a–e), and 14(a)). Further, the complex degrada-
tion of the same myelin leaves large adaxonal
spaces and an axonal content compressed to
totally unwrapped myelin in the same area where
typical, undulating tight myelin occurs and identi-
fies the juxta- and paranodal zones (Figures 4(b),
13(a–e), 14(a–c), and 15). In the same paranodal
zones, myelin keeps some of its interconnected
membranes leaving remaining ones attached
across the annulus with clear intermembranous,
somewhat punctate junctions. These encompass
SC’s outer membrane leaflet contacts albeit most
of it is fissured by small intraperiod elongated
vacuoles, (Figures 9 and 14(b,c)). There, even
though the myelin ravages tear apart the entire
width of its annulus morphology, it remains form
a distorted, multicurved outline where displaced
layers of membranes are still retained together.
Cross-sections of those teased membranes,
amassed with defects, appear as if they were bales
of wires (Figure 14(b)). Following the most ulti-
mate disengagement of the myelin ring in the near
internode and paranode regions, the adaxonal
membrane that has maintained the neurolemma
out of the insulating defects can show breaches
without that of the neuroplasm (Figures 13(b)
and 14(a–c)).
Again, demyelination would likely interfere or
obliterate some of the Zucker nerve conductivity,
as it was suggested by exercise tests. 27 It is inter-
esting to view an enlarged small sector out of a
typical myelin damage micrograph to verify that
intraperiod line densities remain as small interper-
iod, elongated contrasted dots, or line-like densi-
ties spaced between the major dense lines unless
they become excessively displaced by some inter-
cellular gaps (Figure 9). The gaps can correspond
with intercellular charged components admixed
onto the glycocalyx and rafts. These alterations
change the typical myelin stratification and stiff-
ness thus causing demyelinating defects with
excess in extracellular accumulated repelling
charges contributing to separate them by narrow
to large gaps (Figures 7(a) and 9).
Unmyelinated fibers. Even though most of the
nerve fibers of the tibial branches of the sciatic nerves
are motor neurons 67, only a few Remak fibers’
membranes examined appear to contain higher elec-
tron-contrasted zones when compared with lean
ones (Figure 4(b)). However, more data are needed
to comment on these scarce observations.
Endoneurium and supportive stroma. Figure 4(b)
reveals a very loose endoneurium, maybe brought
by some surrounding changes. Figure 5(c) also
demonstrates the endoneurium layer, charged
with numerous vacuoles – including many densely
contrasted ones – suggests some lipid content get-
ting in close contact with the outer Cajal band,
Figure 17. Diagrammatic representation of a suggested, unex-
pected peculiar centripetal diffusion (blue arrows) of myelin
compound(s) dispatched by Schwann cells. Axon in black.
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probably spaced by the fixative processing,
wherein no basal lamina is displayed. This obser-
vation signals further investigations could be done
along with old data suspecting this layer to be
involved in myelination by SCs and their associa-
tion in peripheral neuropathy associated with dia-
betes or in NIDDM condition.
Discussion
Based on the ultrastructural data of this study, a
main specific cause for the myelin defects points to
and comforts the leptin receptor mutation.
However, how and which myelin component(s)
is (are) involved cannot be pinpointed. The enor-
mous literature dealing with myelin, added to the
leptin receptor mutation, suggests this myelinopa-
thy can be caused by NIDDM but also by coexist-
ing endocrinopathies. We tried in the following
paragraphs to explain the myelin changes collected
in this rodent that probably disclose comparable
nerve defects to be found in human neuropathol-
ogy. Surprisingly, our ultrastructural findings on
demyelination may justify us to claim to have
unravelled a peculiar centripetal mode of myelin
maintenance in PNS nerves.
Diabetes and peripheral neuropathy
Even though known since Antiquity 6,73, a clinical
descriptive of diabetes has been made by Dobson 74
and throughout the years followed by numerous
authors (e.g. reviews in [4], [6], [42], [55], [75],
[76]). In Ref. 6, one reads that “. . . before Marchal
de Calvi 77, diabetes mellitus was believed to be
secondary to a lesion of the nervous system rather
than the reverse“. . .“ Since that time, most investiga-
tors have accepted that diabetic polyneuropathy is
secondary to the metabolic disorder . . .“. This
excerpt could summarize the etiology of diabetes
type 1 or insulin-dependent diabetes mellitus
(IDDM) and of diabetes type 2 or NIDDM.
However, such 50-year-old etiology has been recon-
sidered and surveyed repeatedly 6,10,46,69,75–86 but not
necessarily with illustrations of the PNS-associated
damages to demonstrate the myelinopathy progres-
sion. 6,79,87,88 Nowadays, specialists of diabetes can
reappraise the old clinical neuropathy explanation 75
in NIDDM because the Zucker rats 40–42,89,90, other
animal studies 6,44,46–53,87–94, and several clinical
cases 6,54–64,78,83–90,95–99 showed the disease to arise
out of perturbations in the hypothalamic-pituitary
axis interacting with other endocrine tissues due to
faulty receptors. These findings make room for new
avenues to understand and fight diabetes because
not only SC’s changes in metabolism with a genetic
origin alters myelin and, maybe, both that of SCs and
connective tissues could be influenced by some other
CNS dysfunctions, thus also contribute or cause PNS
myelinopathy, as shown here with ultrastructure.
The Zucker rat sciatic nerve defects are not
artifacts
At first, the nerve structures found with TEM have
been thought to be artifacts caused by the sample’s
processing because some texts have shown
mechanical manipulations of excisions could
injure myelin. However, after LM examination of
diverse parts of the sciatic nerves, alterations affect
all obese nerve fibers of tibial small branches
including those intramuscular fibers out of dis-
sected muscles obtained after the fixing perfusion.
None of the lean rat nerves of the same tissue
regions show damage while simultaneously pro-
cessed. Furthermore, the architectural damages of
the myelin form discrete and irregular density of
the myelin sheaths. Spotty and distributed
throughout along the length of the insulating mye-
lin (e.g. Figure 5(b,c)), the defects cannot be
caused by mechanic manipulations, friability or
edema of the samples, or processing as they carry
on in diverse directions with delaminating aspects.
The compression damages reviewed [e.g.
100,101,102,103] are segmental, unique and appear
with a more injurious pattern than the ones found in
this study or even than the ones described recently in
rat sciatic with crushed injury. 104 In the largest
branches of the obese rat nerves, most nerve fibers
are myelinated 105 and bore injuries (not totaled in
this report) across all the similarly processed obese
nerve samples. In addition, some of the diamond
knife traces obtained out of sectioning samples
show tiny disruption of the myelin (Figures 5(c)
and 14) but all other micrographs obtained the
same knife, including lean nerves, are artifact-free
and compared well with the micrographs found in
other publications. 105–108 Several studies where
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diabetes has been induced, including with sciatic
nerve cross-sections, have defects in both animal
data 43,44,46–53,55,71–87,91,109,110 and in human biopsies
and of other peripheral nerves 46,73–75,77–89,106–
108,111,112 where myelin is showing some aspects of
ours.
Having established that the myelin injuries are
not artifactually made, one can assume that young
male obese NIDDM rats live with peripheral neu-
ropathy and one would have to relate this PNS
defect with their complex endocrinopathy. The
advances of new information published on this
rodent defects, including some molecular markers,
have stimulated us to submit data collected and
introduced a while ago. 12
PNS myelin and sciatic nerve
Myelin aspects
Throughout the micrographs displayed, the myelin
periodicity of the major dense lines typically ranges
between 12.5 and 17.5 nm for both lean and intact
regions of the obese rat sciatic nerves after perfu-
sion fixation and the supplementary fixation. There,
the major dense lines and intraperiod lines are
preserved, indicating that the constitutive element
has been preserved to retain the myelin lamellar
periodicity, except in the blemished internodal and
paranodal regions. In addition, some of the intact
regions of the obese nerve fibers show intermem-
branous, hyphen-shaped electron dense ticks
(Figures 10 and 13–15) identical to those of the
typical sciatic nerves of rat. 105–108,111,112
Our findings about periodicity can be favorably
compared with the data resolved by cryofixation,
vitrification, and X-ray diffraction studies 113–115 as
well as those pioneering studies with TEM where the
insulation sheath compared to a kind of ‘jelly roll’
formed by the SCs surrounding nerve fibers whether
rats, other animals, or human samples 3,4 andmono-
graphs dealing with structure, molecular organiza-
tion, and physiopathology. 1–4,7,9,87,105–109,111–113,116
SCs and sciatic nerve changes
Even though the dynamic mechanisms by which SC
cytoplasm wraps constitute the enveloping major
dense lines and the extracellular surface contacts
form the minor lines of myelin can now be better
understood than in the earliest investigations, the
distribution and maintenance of many of the myelin
components wrapped in associated sheaths are still
unclear in the PNS 1–6,76,87,117–125; this is especially
true in the diabetes types. 76,78–82,87,88,123,126,127
Recalling numerous investigations, some of them
have clarified the single molecular marker’s turnover
during growth in vivo and in vitro. 3,6,108,121–
123,126,127 However, many PNS nerve fibers owe
large number of membrane wrappings; this more
complex architecture leaves unresolved questions,
compared with those now obtained with some CNS
myelinated ones 3,5,102,106,109,111,116,128–134 and others
found with demyelination diseases especially linked
with autoimmune or genetic defects. 1–7,124,125,131–144
The choice of using sciatic nerve samples in the
Zucker rats has been influenced by the frequent
studies done on this nerve throughout the literature
1–5,87,109,111,116,124,125,136–141 and the easy access of
rat carcasses obtained from local investigators to
initiate our study. The PNS nerve myelin, like the
one made by the oligodendrocytes, contains a huge
proportion of cholesterol. It is thus without surprise
that cholesterol was one of the first lipid investi-
gated with radiolabeled-chase radioautography and
found to be provided by the SCs through long-
itudinal diffusion mode along the cytoplasm and
its extension, the major dense lines, out of the S-L
spaces or incisures, in addition to the neuroplasm,
in a centrifugal fashion. 113,125,129,138–141 If choles-
terol with specific lipoproteins rafts imparts the
large part of the essential myelin architecture or
morphology (layering, curvature with stiffness com-
bined; 125,140,141,142,143,144,132), many other
myelin components have not seen such clear reso-
lution in provenance and placement because they
can be randomly distributed throughout the sheaths
or even via the axoplasm as well as the SCs. 1–4 In
the lipid matrix of myelin, some of the constitutive
glycoproteins (PGs) or proteolipids proteins are
capable of translational diffusion within this bilayer.
1–5,125,133,134,140
It is quite amazing to consider that the SCs huge
management and homework to express and dispatch
properly intrinsic, extrinsic proteins, plasmalogens,
adhesive PGs, and glycolipids and dynamically con-
struct, maintain, and repair a proper myelin mem-
brane’s integrity. 1–5,109,111,116,133,134,141,145–150 Even
though, there are probably other still undiscovered
regulations to be deciphered in the nerve system,
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especially those that would cause defects in PNS
disease-related myelin components to clarify the
etiology and possible treatment of their associated
neuropathies, such as diabetes type 1 (IDDM) differ-
ing from type 2 (NIDDM). 116,127,131 Many studies
have emphasized the CNS defects 109,111,131,134 and
reduced PNS disease’s diagnostics into biopsy stu-
dies. 1–6,87,88 In PNSmyelin, among all its non-phos-
pholipid metabolome, large amounts of PGs or
plasmalogens contribute to its architecture, integrity
of adherence of the neuroplasm, and to nerve pro-
tection and insulation. 150–154 Further, the neuro-
plasm interacts with myelin both ways 155–159, with
cadherins 160–166 and others still to be found 165–168
as well as to place periaxin 169 with connexin 32
(Cx32). 170
The alignment and points of adherence of the
defects can suggest one of the most abundant myelin
PGs involved, such as myelin protein zero (P0) which
core integral protein replaces the proteolipid protein
or PLP found in the CNS myelin. 148,149,171–180 P0
makes homophilic contacts across major dense and
minor lines and contacts others, such as the peripheral
myelin protein 22 (PMP22) 178–180 altogether potent
stabilizers of the myelin 160,179–181 along with the
adaxonal myelin-associated glycoprotein (MAG).
160–164,181 Among them, the discovery of neuregulins
in CNS 182 triggered a series of observations in favor
of its neurotropic activities on myelin differentiation,
adherence, layering, and interactions with the SC
basal lamina in the sciatic nerve in vivo knockout
mice and in vitro 12,183–192, thus engaging possible
new interactions between the immediate endoneurial
layer made by the SCs and possibly an external influ-
ence of components of this endoneurium with the
abaxonal activities to constitute a proper myelin.
Notwithstanding, if a form of neuregulin favors mye-
lination and it alteration can cause for hypomyelina-
tion, hypothyroidism has been already a factor of the
etiologic nerve damage considered inNIDDMZucker
rats. 13,14,27,70,193
Out of old data about diabetes autopsies 194, ana-
lyses of nerves from limb amputations 195, other
human and animal data 47,196–198, cholesterol–phos-
pholipid balance have been noted to be lower than of
normal nerves as well as in components of the mye-
lin. 47,194–200 Thus, the observations support that in
obese Zucker rat nerves, similarly to other animal
models and human, changes in junctional
carbohydrate’s SC’s coating of phospholipids, PGs,
glycolipids could be caused by altered expression due
to a combined hypothyroidism and diabetes fol-
lowed by an excessive Golgi sorting to membrane
negatively charged phospholipids 198, sphingomye-
lins 47,199–201 and sulfatides 199 initiated with endo-
plasmic reticulum stresses. 203–205 In fact, alone,
insulin treatment shows that altered utilization of
glucose and some lipogenic activities can be restored.
204–206 Other possible changes may be associated
with the progressive alterations in nerve vascular
supply and, in some experiments, metabolic changes
even suggest ROS injuries. 202–207 This etiologic
functional maze of interactions reminds us about
previous surveys 76–85,110 and clarifications of
human, Zucker rat, or other animal pathology invol-
ving PNS demyelination in diabetes type 2 could still
come out from further modern verifications, wher-
ever necessary, utilizing knockout murine models.
The myelin and possible causes of the damages
Theminor (extracellular) dense lines excessive hydro-
phobic, inositol-proton rich charges could ‘unzip’
attachment sites of the major dense lines (containing
phospholipids and plasmalogens such as the MAGs,
heavily phosphorylated glycosaminoglycans -i.e.
anion- charged- like the myelin basic protein in
CNS 160–164,181,208, galactosylceramides and sulfatides)
constitute a large proportion of the total membrane
glycolipid mass 75–85,110,126,127,162,209–215 that can be
altered in NIDDM, in addition to the rafts 208,215–216
and along with the S-L incisures. 209
One of the potent supplier for ceramides is the
sphingomyelin synthase 2 (SMS2) 218–223 that is
normally stimulated by leptin. 214,218,221 In fa/fa
Zucker rat tissues, including SCs, they bear a lep-
tin receptor defect which could dull a typical
expression of SMS2 and typical sorting of cera-
mide into sphingomyelin from inner to outer mye-
lin membrane, protracted to support the renewal
of the minor dense line. Insulin insensitivity or
resistance makes a deficient conversion of cera-
mides into sphingomyelins to be incorporated in
the myelin glycosphingolipids 217. This could
mean that an excess of slow-used, perhaps even
of peroxidated ceramides with no charge may
overload and can disturb the major dense lines,
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extensions of the S-L. Reaching the NIDDM gly-
cocalyx, these ceramides add peculiar damages 219
and, following processing of tissues, leave the mye-
lin with stores of lingering, waxy, electron dense
deposits among gaps in myelin extracted altered
lipids.
Compounded with abaxonal origin, any myelin
membrane spacing disruption could also modify not
only its rigid curvature but also create an onion-like
membrane structures through unbalanced lipid-phos-
pholipid-cholesterol content. This failed turnoverwith
accumulation of the initial defect along with other
minor PGs 224 can compromise the integrity of the
myelin. Excess of ceramides can result in a sort of
Wallerian degeneration. 109,111,116,225 However, the
Wallerian degenerative morphology does not fit with
the type of injuries found here since axons are not
segmented 226 and the described injuries do not com-
pare with other recent diabetes findings. 227
Additionally, traumatic crush defects found in a recent
ultrastructural study, dealing with sciatic nerve in
rodent, are different than our data. 228
Disturbances in the minor dense line with facing
glycocalyx can be caused by some acquisition of exces-
sive anionic repelling charges 198,223 out of a sequen-
tial, decreasing anionic amounts of residues
(phosphorylated > sulfated > carboxylated). 168,195–
199,223 Repelling spaces can be revealed by clear,
unstructured rifts in the fine morphology of the
minor lines, where sciatic myelin external surfaces
with excessive similar charges (sialic acid or asso-
ciated) thus could cause other adherence faults,
increasing disturbances in cooperative PG interac-
tions. Narrow sectors ultimately generate large sectors
of undulating onion layers or extracted since the rafts
could now have modified membrane components
and, thus, alter the tight wrapping of the normal
myelin, as noted in diabetes nerves 226 but with
further, more intense damages.
The demyelination changes of the obese nervemye-
lin, observed at first as narrow spaces or nicks to
channel-like into cones with electron dense contrast,
could originate from the overloads of ceramides as
sphingomyelin precursors in the Cajal bands.
Ceramide channels have been illustrated in model
membranes and other cells 229,230 and correspond
with ceramidase inactivity in obese rats. 231 It can be
hypothesized that themaintenance ofmyelin layers by
the high need of ceramides to form sphingomyelins
produces sorts of molecular trans- and, then, inter-
membranous throughs or channels that could widen
toward the adaxonal myelin zones. Each of generated
directrix comes to an end at the axoplasm surface
where the axolemma appeared preserved. This type
of channeling could be injurious because of the pecu-
liarmyelinmaintenance, delimited to themyelin insu-
lating layer alone. 155–159,166–168 The trans-
membranous passageways across the sort of liquid
crystal-like phase between myelin strata could be cre-
ated by a sort of Rayleigh–Taylor instability. 232,233 In
this case, at first, accumulated molecular species, pas-
sing through undetected pores, appear by processing
as channel-like, with centripetal orientation, widen
into sectors caused by the progressively changedmye-
lin composition and processing extraction of the
samples.
Other interactions exist between lipid rafts and
ceramide or sphingomyelin precursors due to external
glycanized moieties 225–227 and other membrane gly-
colipids. 224 Even though these plasmalogens belong to
the family of immunoglobulins and can provide with
injuries potent antigens toward autoimmune myelin
defects akin to those noted in CNS (e.g. 87, 134) The
absence of inflammatory reactions in sciatic nerve
defects points to amainmetabolic insult toward either
SCs and/or axoplasm (i.e. neural) origin in coopera-
tivity with changed connective stroma of Zucker
NIDDM and some other endocrinopathies discussed
in the following paragraph.
The detection of small ‘marbled’ or ‘pale, fatty-like’
vesicles in the Cajal bands adjacent to or abutting the
myelin abaxonal layer in the obese nerves, not found
in the lean ones, could be another clue linking the
damages to a ‘distribution’ of excessive lipid-contain-
ing to the myelin. At first, one thought to identify the
vesicles with lysosomes, where excessive loads of low
pH and acid phosphatases with mannose could pro-
duce electron densities with the Golgi sorting pro-
cesses but they are not membrane-bound. Therefore,
the nature of granular-like deposits in the initial mye-
lin defects cannot make them Reich or Π (lysosome)
bodies parts of the PNS appearing through the dense
line-extensions of the S-L spaces. 234–237
For the sake of completion about myelin defects,
neuregulin-1 12,182–192,234,238, 243 that has been shown
to control myelin thickness in relationship with the
axoplasm through a suggested ‘centrifugal diffusion’.
193 However, out of the electron micrographic
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illustrations of the same 193 publication, the knock-out
‘control’murine strain’ demonstratesmyelin regularly
spaced defects that appeared similar with those
observed in this study. It is near or at the level of the
Ranvier’s nodes, or the juxtanode areas that the teared
or ‘unzipping’ of the usual tight adhesion occurs
between the myelin membranes and the axolemma.
1–6,107,108,119,134,146,239–242
Out of all the main points discussed, myelination
and its maintenance require the activation and high-
level expression of myelin-specific genes of the SCs
producing numerous specialized membrane compo-
nents 190 with minor cooperative influences of the
axon. 126,140,147,148 As such, demyelination that has
been found in this investigation with diabetes type 2/
NIDDM Zucker rats is mainly caused by a single
amino acid change in the leptin receptor, limited to
internodal and juxtanodal zones without involvement
of the axon components. However, as noted in a
previous paragraph, this genetic etiology results not
only out of NIDDM but also can be caused by con-
voluted associated endocrinopathies where the inca-
pacitated central control further influences several
organ's functionality. Among those, one cannot
exclude the interstitial endoneurium metabolism and
its vascular supply as these components still need
further clarifications 8–10,86 Indeed, diabetes type 2
damages differ from those of diabetes type 1 because
in IDMM more widespread peripheral neuropathic
changes would be found and include nodal defects,
whether in animal 48,49,84,93,127 or human observations
53,55,79 or in both. 47,96,97,134,197
The obese Zucker rat leptin receptor mutation
defect is exacerbated by other endocrinopathies
The adipokine leptin is without receptors in obese
Zucker rat
The circulating adipokine leptin has been identified in
wild and obese mice, and cloned. 35,88,244–247 Then,
leptin became important in clinics to understand biol-
ogy of obesity and diabetes with a considerable biblio-
graphy. 248–251 Leptin receptors have been cloned and
localized in rat CNS areas, including the lean and
obese Zucker strains. The arcuate nucleus, the choroid
plexus, and the hypothalamus-pituitary-adrenal axis
have the receptors even though unresponsive in obese
ones. 244,251–255 In obese Zucker rats withNIDDM, the
chromosome 5 bears a missense recessive
homozygous mutation of the gene Fa into fa control-
ling the expression of a defective leptin receptor
(named OB-R) caused by a substitution in position
269 of glutamine to proline of the extracellular domain
of that receptor, also expressed in many tissues while
the expression of the receptor long (active) form is
found at normal concentrations in the lean Fa/?
Zucker and most other laboratory or wild rats. 29–35
The obesemice are unable to express leptin but they
have adequate receptors for leptin, therefore, after
injected with it, obesity can be eliminated. 244–250
However, obeseZucker fa/fa rats haveno such suitable
receptors, including in the stomach, where ghrelin is
expressed and is known to suppress the hunger stimu-
lus of the CNS arcuate nucleus. 244,256–260 The leptin
receptor flaw makes fa/fa rats subjects to an agonistic
autocrine activity inciting gluttony that further ampli-
fies adipose tissue’s leptin expression. They live with a
chronic sevenfold normal serum leptin level.
28,31,32,36,246,256 This leptin plethora without receptor
severs the normal hypothalamo-pituitary (and
pineal?) axis functions (endocrines, circadian
rhythms, etc.). It is quite possible that, similarly in
similar human cases, an equivalent defective receptor
mutation, also localized in chromosome 7q, translates
into faulty leptin receptor causing congenital obesity
54–66,88,244,246,261–264 that can influence insulin activity.
38,54–66,263,264 In these human cases, demyelination
defects have yet to be found and studied.
Central signals to periphery changes include PNS
and adrenal maintenance along with inadequate
reproductive activities and metabolism. 244,262–264
These changes have impact on myelin maintenance
due to thyroid 14,15,19–25,43,265, growth hormone/pro-
lactin 40–42,266,267 deficiencies in addition to gonado-
tropic 41,42,58,266,267, corticotropic 264–269, and POMC
signaling defects 60,264,266,
A diminished external and SC’s neurosteroid pro-
gesterone activity, alongwith that of adrenal secretion,
can contribute to restrain the expressions of P0 and
PMP22 plasmalogens. 160–162,165,167,171–181,184,270
However, there are some remaining linkers in the
worse damaged myelin.
The SCs in the obese nerves and
neuroprogesterone
A lack of leptin receptors in the adenohypophysis
can also disturb activities of most basophils,
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especially the gonadotrophs and POMC-making
cells, thus alters SCs endogenous SC steroids pro-
duction that further impact on peripheral neuro-
pathy found with NIDDM of Zucker rats, and in
similar human defects 262,263 when compared with
normal subjects. 271 If neurosteroids can prevent
myelin alterations caused by diabetes 272, verifica-
tions of neurosteroid changes are yet to come in
Zucker rat to comfort this influence on the sciatic
nerve defects. Repairs can be promoted through an
external neuroactive steroid-like progesterone (P)
thus this sex steroid could then become a preven-
tative or repair way to reestablish the lipid myelin
alterations in diabetics. 272–275
The expression and metabolism of neuroster-
oids in the vertebrate nervous system have been
studied in the PNS by Melcangi’s laboratory and
others. 276–286 In PNS, SCs are a major local source
of growth factors and neurosteroids with internal
P receptors. 278,279 P acts as an autocrine regula-
tory mechanism involved in myelination. 270,277,281
Neuroprogesterone synthesis by SCs in the PNS
were confirmed with cytochrome P450scc (ssc:
side-chain cleavage enzyme) and 3β-hydroxyster-
oid dehydrogenase/Δ5-4 isomerase mRNA (or 3β-
HSD mRNA) found to be markedly regulated in
myelinating cocultures of dorsal root ganglion
neurons and SCs. These mRNAs were exclusively
localized in the SCs. 282–284 Importantly, after scia-
tic nerve lesion, the upregulation of 3β-HSD
mRNA correlated with the expression of plasma-
logens P0 and PMP22 mRNAs which are also
stimulated by P and by 5α-dihydroprogesterone
treatment in the sciatic nerve in vivo and in cul-
tured SCs. Isolated from neonatal rat sciatic nerves
SCs in vitro the previous enzyme activities convert
25-hydroxycholesterol, a cholesterol metabolite
which easily crosses cell membranes, into pregne-
nolone. 283 Pregnenolone was found to be higher
in male rat sciatic nerves than in plasma; those
levels were not reduced by castration and adrena-
lectomy, strongly suggesting a local synthesis of
the direct precursor of progesterone, independent
of external endocrine sources. In consequence, one
could add internal SC’s neurosteroid anomalies in
the list of defects associated or caused by leptin
receptor’s inactivation.
Therefore, it seems coherent to propose, in
addition to NIDDM 47,133,134,194–197,226, that leptin
receptor defect of the young male obese Zucker
rats can associate with a demyelination due to lack
or depletion of sustaining neurosteroids. 285–287
However, it is not currently proven whether leptin
could directly influence the SC’s functions. 288,289
Endoneurial support and myelin
Leptin receptors can modulate signals of the endo-
neurial fibroblast’s lipid metabolism. This possibi-
lity is only supported by a few studies. 9,289 It is not
too surprising since the endoneurium and SC basal
lamina are linked with the ground substance to
sustain myelin growth. 8,10,11,84,148,290,291 This
endoneurium also influences myelin reconstruc-
tion and can be astutely instilled by recent con-
tributions complementing old ones because SCs
also reveal ownership of a plasticity for myelin
reconstruction due to epithelio-mesenchymal tran-
sition. 288 Through this means, steroid hormones
(androgens and thyroid ones), other factors
126,149,168,182–184,292–294, and still unknown signals
can control SC’s transcript expressions in main-
taining a ‘correct’ PNS myelin composition and
architecture.
Conclusions
The opportunity to have collected sciatic nerve
long segments of the obese Zucker rat carcasses
that bore a single amino acid mutation in the
adiponectin leptin receptor not only makes this
cytokine able to influence CNS tissues but also
affects PNS nerve myelin directly or indirectly on
the SCs metabolome 75,84,85,89,90,194,295–296
(Figure 15). This unique genetic defect has multi-
ple entwined systemic/metabolic alterations that
allow us to have observed and described progres-
sive and large PNS ultrastructural damages limited
to myelin (Figure 16). The myelinopathy seems
mainly caused by the altered membrane content.
With NIDDM disease 78,130, the data suggest that
the membrane’s maintenance appears to have failed
because membranes seem to have ‘liquefied’ due to
lack of adequate cholesterol and modified PLPs
(rafts 297) in the internodal sectors. Instead, some
unsaturated lipids accompanied by intermembra-
nous locks – i.e. PGs or glycolipids but mostly
sphingomyelin types – have been maintained. 95,97
ULTRASTRUCTURAL PATHOLOGY 397
The SC defects could be amplified by changes in
neurosteroids linked with this leptin receptor muta-
tion. As shown in the previous paragraphs, several
questions remain to verify the regulation of the
myelin metabolome in normal vs. diabetes type 2
condition.
Furthermore, the imagery unveiled with this
NIDDM model hopefully contributes and supple-
ments by their details the few ultrastructural data
reported in the PNS to diagnose this endocrine defect
in animals 1–6,47–53 and, maybe, in human diabetes
type 2 and/or some complex forms of the same dis-
ease. 54–58,75,97–99,194,195,295,296,298 Additionally, to
assist in understanding how some pattern of damages
can alter the peripheral neural conduction. Thus,
another direct and indirect role of leptin, an adipo-
kine, on PNS maintenance and with CNS
interactions, 295,296 can be proposed as one has sche-
matically illustrated in Figure 17.
Finally, the nerve defects described may have
divulged an additional mode of maintenance of the
PNS myelin by SCs through a kind of penetration-
diffusion, diagrammatically depicted in Figure 16:
some peculiar, myelin components, detected and
illustrated in several micrographs appear in excess,
faulty moieties or charges (maybe ceramides meta-
bolites?). Issued from the SC’s abaxonal regions they
would be centripetally inserted in the myelin mem-
brane layers and, through instable diffusion, trans-
ferred across myelin membranes, using flipping
channels with spillage across the myelin layers. In
so doing, the mechanism alters the intrinsic mem-
brane rafts in addition to the diffusion already
demonstrated in the CNS myelin with longitudinal-
spiral diffusion out of the near nodal (juxta- and
paranodal) Ranvier’s zones toward the internodal
region. 128–130
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